MGRX — Mangoceuticals Balance Sheet
0.000.00%
- $23.20m
- $23.12m
- $0.62m
Annual balance sheet for Mangoceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | 0.023 | 0.683 | 0.739 | 0.059 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 0.023 | 0.695 | 0.818 | 0.076 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0 | 0.292 | 0.215 | 0.062 |
Net Intangible Assets | ||||
Other Long Term Assets | ||||
Total Assets | 0.023 | 1 | 1.05 | 15.4 |
Payable / Accrued | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 0.039 | 0.261 | 0.211 | 1.43 |
Total Long Term Debt | ||||
Total Debt | ||||
Minority Interest | ||||
Total Other Liabilities | ||||
Total Liabilities | 0.039 | 0.389 | 0.276 | 1.42 |
Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | -0.017 | 0.614 | 0.775 | 13.9 |
Total Liabilities & Shareholders' Equity | 0.023 | 1 | 1.05 | 15.4 |
Total Common Shares Outstanding | ||||
Total Preferred Shares Outstanding |